Information  X 
Enter a valid email address

Arix Bioscience PLC 0.001P (ARIX)

Date Time Source Announcement
18 Oct 2021 4:47 pm
EQS
LogicBio Therapeutics Announces Early Clinical Trial Results Demonstrating First-Ever In Vivo Genome Editing in Children
  7:00 am
EQS
Business Update and Cancellation of Share Buyback
15 Oct 2021 5:30 pm
EQS
Transaction in own shares
14 Oct 2021 5:30 pm
EQS
Transaction in own shares
13 Oct 2021 5:30 pm
EQS
Transaction in own shares
  5:28 pm
EQS
TR1: Notification of Major Shareholding
12 Oct 2021 5:30 pm
EQS
Transaction in own shares
  1:01 pm
EQS
Aura Biosciences Presents Interim Phase 2 Safety Data Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma at the ASRS 2021 Annual Meeting
11 Oct 2021 5:30 pm
EQS
Transaction in own shares
08 Oct 2021 5:30 pm
EQS
Transaction in own shares
  10:10 am
EQS
Pyxis Oncology prices Nasdaq IPO - Update
  7:00 am
EQS
Pyxis Oncology prices Nasdaq IPO
07 Oct 2021 5:30 pm
EQS
Transaction in own shares
06 Oct 2021 5:30 pm
EQS
Transaction in own shares
  7:00 am
EQS
Board Changes
05 Oct 2021 5:30 pm
EQS
Transaction in own shares
04 Oct 2021 5:30 pm
EQS
Transaction in own shares
01 Oct 2021 5:30 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
30 Sep 2021 5:30 pm
EQS
Transaction in own shares
29 Sep 2021 5:30 pm
EQS
Transaction in own shares
28 Sep 2021 5:30 pm
EQS
Transaction in own shares
  8:15 am
EQS
Artios Doses First Patient in Phase 1/2a Study of Pol? Inhibitor ART4215
27 Sep 2021 5:30 pm
EQS
Transaction in own shares
24 Sep 2021 5:30 pm
EQS
Transaction in own shares
23 Sep 2021 5:30 pm
EQS
Transaction in own shares
22 Sep 2021 5:30 pm
EQS
Transaction in own shares
21 Sep 2021 6:00 pm
EQS
Transaction in own shares
20 Sep 2021 5:30 pm
EQS
Transaction in own shares
17 Sep 2021 5:30 pm
EQS
Transaction in own shares
16 Sep 2021 6:00 pm
EQS
Transaction in own shares
15 Sep 2021 5:30 pm
EQS
Transaction in own shares
14 Sep 2021 5:30 pm
EQS
Transaction in own shares
13 Sep 2021 5:30 pm
EQS
Transaction in own shares
10 Sep 2021 5:30 pm
EQS
Transaction in own shares
09 Sep 2021 5:30 pm
EQS
Transaction in own shares
08 Sep 2021 5:30 pm
EQS
Transaction in own shares
07 Sep 2021 5:30 pm
EQS
Transaction in own shares
06 Sep 2021 5:30 pm
EQS
Transaction in own shares
03 Sep 2021 5:30 pm
EQS
Transaction in own shares
02 Sep 2021 5:30 pm
EQS
Transaction in own shares
  11:20 am
EQS
Arix Bioscience participates in $90 million Series B financing for Disc Medicine
01 Sep 2021 5:30 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
31 Aug 2021 5:30 pm
EQS
Transaction in own shares
27 Aug 2021 5:30 pm
EQS
Transaction in own shares
26 Aug 2021 5:30 pm
EQS
Transaction in own shares
25 Aug 2021 5:30 pm
EQS
Transaction in own shares
24 Aug 2021 5:30 pm
EQS
Transaction in own shares
23 Aug 2021 5:30 pm
EQS
Transaction in own shares
20 Aug 2021 5:30 pm
EQS
Transaction in own shares
19 Aug 2021 5:15 pm
EQS
Transaction in own shares
18 Aug 2021 5:30 pm
EQS
Transaction in own shares
17 Aug 2021 5:45 pm
EQS
Transaction in own shares
16 Aug 2021 5:30 pm
EQS
Transaction in own shares
  7:00 am
EQS
Director/PDMR Shareholding
13 Aug 2021 5:30 pm
EQS
Transaction in own shares
12 Aug 2021 5:30 pm
EQS
Transaction in own shares
  7:00 am
EQS
Interim Results for the Six Months Ended 30 June 2021
11 Aug 2021 5:30 pm
EQS
Transaction in own shares
10 Aug 2021 5:30 pm
EQS
Transaction in own shares
09 Aug 2021 5:30 pm
EQS
Transaction in own shares
06 Aug 2021 5:30 pm
EQS
Transaction in own shares
05 Aug 2021 5:15 pm
EQS
Transaction in own shares
04 Aug 2021 5:28 pm
EQS
Transaction in own shares
03 Aug 2021 5:20 pm
EQS
Transaction in own shares
02 Aug 2021 5:25 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
30 Jul 2021 5:15 pm
EQS
Transaction in own shares
29 Jul 2021 5:30 pm
EQS
Transaction in own shares
28 Jul 2021 5:30 pm
EQS
Transaction in own shares
27 Jul 2021 5:05 pm
EQS
Transaction in own shares
  7:02 am
EQS
Artios raises $153m in Series C financing
26 Jul 2021 5:00 pm
EQS
Transaction in own shares
23 Jul 2021 5:05 pm
EQS
Transaction in own shares
22 Jul 2021 5:07 pm
EQS
Transaction in own shares
21 Jul 2021 5:18 pm
EQS
Transaction in own shares
  7:00 am
EQS
Notice of Results
20 Jul 2021 5:14 pm
EQS
Transaction in own shares
19 Jul 2021 5:18 pm
EQS
Transaction in own shares
16 Jul 2021 5:20 pm
EQS
Transaction in own shares
15 Jul 2021 5:18 pm
EQS
Transaction in own shares
14 Jul 2021 5:08 pm
EQS
Transaction in own shares
  9:00 am
EQS
Imara announces pricing of public offering
  7:00 am
EQS
Transaction in own shares
12 Jul 2021 5:32 pm
EQS
Transaction in own shares
08 Jul 2021 5:14 pm
EQS
Transaction in own shares
07 Jul 2021 5:37 pm
EQS
Transaction in own shares
06 Jul 2021 5:26 pm
EQS
Transaction in own shares
  7:00 am
EQS
Team changes
05 Jul 2021 4:57 pm
EQS
Transaction in own shares
01 Jul 2021 5:08 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
30 Jun 2021 4:58 pm
EQS
Transaction in own shares
29 Jun 2021 4:52 pm
EQS
Transaction in own shares
28 Jun 2021 5:36 pm
EQS
Transaction in own shares
25 Jun 2021 4:57 pm
EQS
Transaction in own shares
24 Jun 2021 5:20 pm
EQS
Transaction in own shares
23 Jun 2021 5:05 pm
EQS
Transaction in own shares
22 Jun 2021 5:18 pm
EQS
Transaction in own shares
21 Jun 2021 5:05 pm
EQS
Transaction in own shares
18 Jun 2021 5:13 pm
EQS
Transaction in own shares
17 Jun 2021 5:12 pm
EQS
Transaction in own shares
16 Jun 2021 5:25 pm
EQS
Transaction in own shares
15 Jun 2021 5:39 pm
EQS
Transaction in own shares
14 Jun 2021 5:20 pm
EQS
Transaction in own shares
  2:55 pm
EQS
Results of Annual General Meeting
11 Jun 2021 5:00 pm
EQS
Transaction in own shares
  1:05 pm
EQS
Clinical portfolio update
10 Jun 2021 5:25 pm
EQS
Transaction in own shares
09 Jun 2021 5:14 pm
EQS
Transaction in own shares
08 Jun 2021 5:14 pm
EQS
Transaction in own shares
07 Jun 2021 5:07 pm
EQS
Transaction in own shares
04 Jun 2021 5:12 pm
EQS
Transaction in own shares
  3:25 pm
EQS
Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting
03 Jun 2021 5:33 pm
EQS
Transaction in own shares
02 Jun 2021 5:11 pm
EQS
Transaction in own shares
01 Jun 2021 5:35 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
28 May 2021 4:55 pm
EQS
Transaction in own shares
27 May 2021 4:57 pm
EQS
Transaction in own shares
26 May 2021 4:52 pm
EQS
Transaction in own shares
25 May 2021 5:23 pm
EQS
Transaction in own shares
24 May 2021 5:03 pm
EQS
Transaction in own shares
21 May 2021 5:09 pm
EQS
Transaction in own shares
20 May 2021 5:27 pm
EQS
Transaction in own shares
  7:00 am
EQS
Change of registered office
19 May 2021 5:05 pm
EQS
Transaction in own shares
18 May 2021 5:32 pm
EQS
Transaction in own shares
  7:00 am
EQS
Notice of 2021 Annual General Meeting
17 May 2021 5:40 pm
EQS
Transaction in own shares
14 May 2021 5:02 pm
EQS
Transaction in own shares
13 May 2021 5:15 pm
EQS
Transaction in own shares
12 May 2021 5:11 pm
EQS
Transaction in own shares
  4:35 pm
EQS
Autolus�to present additional data in AUTO1 in IBCL
11 May 2021 5:42 pm
EQS
Transaction in own shares
10 May 2021 5:21 pm
EQS
Transaction in own shares
07 May 2021 5:19 pm
EQS
Transaction in own shares
06 May 2021 5:23 pm
EQS
Transaction in own shares
05 May 2021 5:16 pm
EQS
Transaction in own shares
04 May 2021 5:14 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
30 Apr 2021 4:58 pm
EQS
Transaction in own shares
  7:00 am
EQS
Outcome of Strategic Implementation Review and Directorate Change
29 Apr 2021 5:09 pm
EQS
Transaction in own shares
28 Apr 2021 5:14 pm
EQS
Transaction in own shares
  12:02 pm
EQS
Amplyx Pharmaceuticals acquired by Pfizer
27 Apr 2021 5:29 pm
EQS
Transaction in own shares
  2:00 pm
EQS
LogicBio announces clinical and corporate updates
26 Apr 2021 5:32 pm
EQS
Transaction in own shares
23 Apr 2021 5:11 pm
EQS
Transaction in own shares
22 Apr 2021 5:14 pm
EQS
Transaction in own shares
21 Apr 2021 5:26 pm
EQS
Transaction in own shares
20 Apr 2021 5:30 pm
EQS
Transaction in own shares
19 Apr 2021 5:09 pm
EQS
Transaction in own shares
16 Apr 2021 5:17 pm
EQS
Transaction in own shares
15 Apr 2021 5:08 pm
EQS
Transaction in own shares
14 Apr 2021 5:13 pm
EQS
Transaction in own shares
13 Apr 2021 5:13 pm
EQS
Transaction in own shares
12 Apr 2021 5:22 pm
EQS
Transaction in own shares
09 Apr 2021 5:43 pm
EQS
Transaction in own shares
08 Apr 2021 5:27 pm
EQS
Transaction in own shares
  8:19 am
RNS
Proactive One2One Virtual Investor Forum
  7:00 am
EQS
Arix to Present at the Proactive One2One Virtual Investor Forum
07 Apr 2021 5:46 pm
EQS
Transaction in own shares
  7:00 am
EQS
Artios announces collaboration with Novartis to create next generation DDR cancer therapies
06 Apr 2021 5:25 pm
EQS
Transaction in own shares
01 Apr 2021 5:19 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
31 Mar 2021 5:38 pm
EQS
Transaction in own shares
30 Mar 2021 5:08 pm
EQS
Transaction in own shares
  1:01 pm
EQS
Arix leads $152 million Series B financing for Pyxis Oncology
  7:00 am
EQS
Gita Dittmar appointed as Venture Partner
29 Mar 2021 5:14 pm
EQS
Transaction in own shares
  7:00 am
EQS
Board update
26 Mar 2021 5:14 pm
EQS
Transaction in own shares
25 Mar 2021 4:57 pm
EQS
Transaction in own shares
24 Mar 2021 5:04 pm
EQS
Transaction in own shares
  7:00 am
EQS
Strategy Implementation Review
23 Mar 2021 5:27 pm
EQS
Transaction in own shares
22 Mar 2021 5:57 pm
EQS
Transaction in own shares
  11:09 am
EQS
Aura Biosciences announces oversubscribed $80 million financing
  7:00 am
EQS
Share buyback programme of up to �25 million
19 Mar 2021 4:00 pm
EQS
Holding(s) in Company
15 Mar 2021 7:30 am
EQS
Arix Bioscience (ARIX): 32% IRR since inception in 2016
  7:00 am
EQS
Share buyback programme of up to �25 million
10 Mar 2021 7:00 am
EQS
Response to Activist Shareholder Acacia
09 Mar 2021 7:01 am
EQS
Arix founds new portfolio company Twelve Bio
  7:00 am
EQS
Annual Results for the Twelve Months ended 31 December 2020
25 Feb 2021 7:00 am
EQS
Board Changes
15 Feb 2021 9:00 am
EQS
Holding(s) in Company
11 Feb 2021 7:00 am
EQS
Notice of Results
10 Feb 2021 9:00 am
EQS
Autolus announces pricing of public offering
05 Feb 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  9:06 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
18 Jan 2021 7:00 am
EQS
Investment team changes
12 Jan 2021 7:00 am
EQS
Harpoon announces closing of public offering
06 Jan 2021 2:00 pm
EQS
Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease
  10:00 am
EQS
Autolus provides business outlook for 2021 and 2022
31 Dec 2020 9:00 am
RNS
Price Monitoring Extension
21 Dec 2020 7:00 am
EQS
Director Share Purchase
18 Dec 2020 8:00 am
EQS
Completion of sale of VelosBio
11 Dec 2020 7:00 am
EQS
Atox Bio announces FDA acceptance of New Drug Application
08 Dec 2020 3:45 pm
EQS
Harpoon reports clinical progress across all pipeline development programmes
07 Dec 2020 5:47 pm
EQS
Autolus presents additional data on AUTO3 at ASH
  7:15 am
EQS
Arix Bioscience (ARIX): Artios attracts Merck KGaA in deal up to $7bn
  7:00 am
EQS
Autolus presents positive AUTO1 data at ASH
04 Dec 2020 7:01 am
EQS
Holding(s) in Company
  7:00 am
EQS
Holding(s) in Company
03 Dec 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  8:01 am
EQS
Artios and Merck KGaA announce global strategic collaboration
12 Nov 2020 7:00 am
EQS
Arix to Present at the Jefferies Virtual London Healthcare Conference
06 Nov 2020 12:10 pm
EQS
Arix Bioscience (ARIX): Hitting the jackpot
05 Nov 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:38 am
EQS
VelosBio to be acquired by Merck for $2.75 billion
01 Oct 2020 2:40 pm
EQS
LogicBio announces pricing of public offering
21 Sep 2020 11:20 am
EQS
Arix Bioscience (ARIX): Realising the valuation disconnect
18 Sep 2020 8:57 am
EQS
Autolus presents additional AUTO3 data in DLBCL
08 Sep 2020 7:00 am
EQS
Interim Results for the Six Months Ended 30 June 2020
13 Aug 2020 7:07 am
PRN
Notice of Results
10 Aug 2020 12:49 pm
PRN
LogicBio announces IND clearance for LB-001
31 Jul 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:01 am
PRN
Total Voting Rights
20 Jul 2020 1:28 pm
PRN
Amplyx announces positive Phase 2 data
10 Jul 2020 7:53 am
PRN
Atox Bio plans NDA submission for Q3 2020
08 Jul 2020 1:27 pm
PRN
VelosBio completes $137 million Series B financing
01 Jul 2020 7:00 am
PRN
Director/PDMR Shareholding, Issue of Ordinary Shares
12 Jun 2020 2:24 pm
PRN
Aura presents updated AU-011 clinical data at ARVO 2020
  1:34 pm
PRN
Imara presents positive interim Phase 2a data at EHA
  9:13 am
PRN
Autolus AUTO1 and AUTO3 data at EHA
08 Jun 2020 7:08 am
PRN
Arix announces strategic and operational update
04 Jun 2020 5:42 pm
PRN
Results of Annual General Meeting
01 Jun 2020 2:57 pm
PRN
Iterum announces topline Phase 3 data in complicated UTI
29 May 2020 1:38 pm
PRN
Harpoon presents interim Phase 1 data for HPN424
  1:06 pm
PRN
Autolus presents additional AUTO3 data in DLBCL
27 May 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
20 May 2020 7:00 am
PRN
Amplyx closes $53 million Series C extension
19 May 2020 9:35 am
EQS
Arix Bioscience (ARIX): 1Q'20 portfolio update
12 May 2020 7:00 am
PRN
Notice of Annual General Meeting
28 Apr 2020 9:23 am
PRN
Pharmaxis announces new data in myelofibrosis
27 Apr 2020 1:12 pm
PRN
Harpoon doses first patient in multiple myeloma trial
23 Apr 2020 7:30 am
EQS
Arix Bioscience (ARIX): Resetting the stage
17 Apr 2020 2:59 pm
PRN
Director/PDMR Shareholding
16 Apr 2020 1:08 pm
PRN
Autolus announces FDA acceptance of IND application
06 Apr 2020 7:00 am
PRN
Changes to Board of Directors and executive leadership
19 Mar 2020 10:30 am
EQS
Arix Bioscience (ARIX): Fiscal 2019 - moving with the times
16 Mar 2020 7:00 am
PRN
Director/PDMR Shareholding
12 Mar 2020 7:11 am
PRN
Imara prices Nasdaq IPO
10 Mar 2020 7:00 am
PRN
Annual Results for the year ended 31 December 2019
09 Mar 2020 12:00 pm
PRN
Dr Roberto Iacone appointed as EiR
03 Mar 2020 12:18 pm
PRN
Update on Imara proposed IPO in the United States
  7:30 am
EQS
Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)
27 Feb 2020 12:00 pm
PRN
Notice of Results
24 Feb 2020 1:26 pm
PRN
Aura announces updated Phase 1b/2 clinical data
19 Feb 2020 7:30 am
EQS
Arix Bioscience (ARIX) - Initiation of coverage: With high risk can come high reward
17 Feb 2020 7:00 am
PRN
Imara files for proposed IPO in the United States
30 Jan 2020 12:08 pm
PRN
Autolus presents encouraging additional AUTO3 data
27 Jan 2020 7:00 am
PRN
Arix co-founds Quench Bio with Series A financing
23 Jan 2020 7:00 am
PRN
Autolus announces pricing of public offering
17 Jan 2020 1:15 pm
PRN
Iterum announces $52 million private placement
18 Dec 2019 10:00 am
PRN
Pharmaxis business update
17 Dec 2019 10:57 am
PRN
Board changes
11 Dec 2019 7:05 am
PRN
Iterum announces topline Phase 3 data
09 Dec 2019 7:01 am
PRN
Autolus announces new AUTO3 data at ASH
  7:00 am
PRN
Autolus announces key new data at ASH
22 Nov 2019 9:57 am
PRN
Holding(s) in Company
21 Nov 2019 12:06 pm
PRN
Harpoon and AbbVie announce licensing and option deal
07 Nov 2019 12:22 pm
PRN
Autolus reports Q3 2019 financial results
  7:22 am
PRN
Change of Broker
06 Nov 2019 2:31 pm
PRN
Autolus to present new data at the ASH Annual Meeting
  7:02 am
PRN
Artios expands DDR pipeline with new asset
17 Oct 2019 1:40 pm
PRN
Holding(s) in Company
16 Oct 2019 8:00 am
PRN
Aura reports updated Phase 1b/2 clinical data for AU-011
15 Oct 2019 3:20 pm
PRN
]Holding(s) in Company
03 Oct 2019 7:06 am
PRN
2019 Capital Markets Day
02 Oct 2019 7:00 am
PRN
Management change
30 Sep 2019 7:00 am
PRN
Arix co-leads EUR 20m Series A financing in STipe
17 Sep 2019 7:47 am
PRN
Amplyx unveils expanded pipeline and Phase 2 data
28 Aug 2019 7:00 am
PRN
Interim results for the six months ended 30 June 2019
20 Aug 2019 7:25 am
PRN
Notice of Results
08 Aug 2019 1:03 pm
PRN
Autolus reports Q2 2019 financial results
01 Aug 2019 7:00 am
PRN
Total Voting Rights
08 Jul 2019 3:34 pm
PRN
Holding(s) in Company
03 Jul 2019 7:00 am
PRN
Issue of Ordinary Shares, TVR, PDMR Notifications
28 Jun 2019 3:22 pm
PRN
Holding(s) in Company
25 Jun 2019 4:17 pm
PRN
Holding(s) in Company
18 Jun 2019 5:23 pm
PRN
Holding(s) in Company
03 Jun 2019 5:51 pm
PRN
Correction: Result of AGM
  5:16 pm
PRN
Result of AGM
  7:00 am
PRN
Total Voting Rights
10 May 2019 7:00 am
PRN
Director/PDMR Shareholding
01 May 2019 7:00 am
PRN
Issue of Ordinary Shares and Total Voting Rights
16 Apr 2019 7:00 am
PRN
Autolus announces closing of public offering
11 Apr 2019 7:00 am
PRN
Autolus announces pricing of public offering
09 Apr 2019 7:00 am
PRN
Autolus announces launch of proposed public offering
02 Apr 2019 7:08 am
PRN
Aura completes $40 million Series D financing
01 Apr 2019 6:10 pm
PRN
Autolus presents initial AUTO1 data at AACR
28 Mar 2019 7:00 am
PRN
Annual Results for the year ended 31 December 2018
  7:00 am
PRN
Board changes
26 Mar 2019 10:17 am
PRN
Autolus hosts R&D day and provides update on AUTO3
20 Mar 2019 12:23 pm
PRN
Notice of Results
18 Mar 2019 7:00 am
PRN
Arix co-leads $63m Series B investment round for Imara
19 Feb 2019 12:12 pm
PRN
Autolus announces updated results from CARPALL trial
  7:00 am
PRN
Management and Board changes
14 Feb 2019 7:00 am
PRN
Harpoon closes initial public offering
08 Feb 2019 7:09 am
PRN
Harpoon prices Nasdaq IPO
01 Feb 2019 10:38 am
PRN
Total Voting Rights
29 Jan 2019 2:25 pm
PRN
Update on Harpoon proposed IPO in the United States
03 Jan 2019 7:00 am
PRN
Issue of Ordinary Shares and Total Voting Rights
28 Dec 2018 7:00 am
PRN
Harpoon announces proposed public offering in the US
11 Dec 2018 7:00 am
PRN
Arix appoints Dr Christian Schetter as EIR
03 Dec 2018 7:00 am
PRN
Autolus announces update on AUTO4 and AUTO5 programmes
  7:00 am
PRN
Autolus presents initial AUTO3 clinical data at ASH
15 Nov 2018 7:00 am
PRN
Positive Phase 1 clinical trial results
12 Nov 2018 7:00 am
PRN
Arix invests in $70m Harpoon Series C investment round
02 Nov 2018 11:33 am
PRN
Autolus Therapeutics to Present New Data at the ASH
30 Oct 2018 2:11 pm
PRN
Aura Biosciences reports positive Phase 1b/2 data
24 Oct 2018 7:00 am
PRN
LogicBio announces closing of initial public offering
19 Oct 2018 7:00 am
PRN
LogicBio prices Nasdaq IPO
10 Oct 2018 7:00 am
PRN
Update on LogicBio proposed IPO in the United States
01 Oct 2018 7:00 am
PRN
Co-leads $58 million Series A for VelosBio
26 Sep 2018 7:00 am
PRN
LogicBio files registration for proposed IPO in the US
18 Sep 2018 2:00 pm
PRN
Update on Iterum Therapeutics Phase 3 trials
12 Sep 2018 4:30 pm
PRN
Announces Board Changes
10 Sep 2018 4:24 pm
PRN
Holding(s) in Company
04 Sep 2018 7:00 am
PRN
Changes announced to executive team
17 Aug 2018 1:01 pm
PRN
Holdings in Company and Lock-in Agreement
10 Aug 2018 7:01 am
PRN
Positive clinical progression in Group Businesses
  7:00 am
PRN
Artios completes �65m Series B investment round
06 Aug 2018 7:00 am
PRN
Arix Bioscience announces first VIPE investment
30 Jul 2018 7:00 am
PRN
Interim Results for the Six Months Ended 30 June 2018
25 Jul 2018 4:41 pm
PRN
Notice of Results
02 Jul 2018 1:16 pm
PRN
Total Voting Rights
26 Jun 2018 5:30 pm
PRN
Autolus annouces closing of IPO
22 Jun 2018 7:07 am
PRN
Autolus Announces Pricing of Initial Public Offering
21 Jun 2018 10:22 am
PRN
Issue of Shares, Total Voting Rights & PDMR Notification
11 Jun 2018 4:23 pm
PRN
Director/PDMR Shareholding
08 Jun 2018 11:36 am
PRN
Update on Autolus proposed NASDAQ IPO
31 May 2018 2:00 pm
PRN
Lord John Hutton steps down from Board of Directors
30 May 2018 4:13 pm
PRN
Iterum Therapeutics plc Closes Initial Public Offering
25 May 2018 7:19 am
PRN
Iterum Therapeutics plc Prices Initial Public Offering
17 May 2018 12:29 pm
RNS
Result of AGM
  7:00 am
RNS
Update on Iterum proposed NASDAQ IPO
08 May 2018 7:00 am
RNS
Autolus Files for Proposed US IPO
02 May 2018 10:10 am
RNS
Arix notes Iterum?s proposed US IPO
23 Apr 2018 7:00 am
RNS
Annual Results 2017
16 Apr 2018 7:25 am
RNS
Notice of Annual Results
05 Apr 2018 7:00 am
RNS
Arix to present at HC Wainwright on 10 April
04 Apr 2018 9:01 am
RNS
Holding(s) in Company
  9:00 am
RNS
Total Voting Rights
26 Mar 2018 1:40 pm
RNS
Holding(s) in Company
  12:31 pm
RNS
Arix notes positive Ph2b COPD data from Verona
23 Mar 2018 9:00 am
RNS
Holding(s) in Company
22 Mar 2018 11:51 am
RNS
Holding(s) in Company
21 Mar 2018 12:46 pm
RNS
Holdings in Company
  11:40 am
RNS
Director/PDMR Shareholding
  11:39 am
RNS
Holding(s) in Company
16 Mar 2018 11:45 am
RNS
Results of General Meeting
  7:00 am
RNS
Results of Capital Raising
06 Mar 2018 7:00 am
RNS
Arix notes Autolus's potential US IPO
28 Feb 2018 11:29 am
RNS
Publication of a Prospectus
  7:00 am
RNS
Proposed Firm Placing, Placing and Offer
21 Feb 2018 7:00 am
RNS
Arix Bioscience and Ipsen sign strategic agreement
19 Feb 2018 7:00 am
RNS
Arix signs strategic agreement with Fosun
04 Jan 2018 2:00 pm
RNS
CEO Letter to Shareholders
03 Jan 2018 9:46 am
RNS
Voting Rights and Capital: Month End Disclosure
22 Dec 2017 7:00 am
RNS
Issue of Ordinary Shares, TVR, PDMR Shareholding
21 Dec 2017 7:00 am
RNS
Arix co-leads $30m financing for Aura Biosciences
04 Dec 2017 7:00 am
RNS
Arix Bioscience leads $30m financing for Atox Bio
10 Nov 2017 9:00 am
RNS
Sir John Banham retires from Board of Directors
01 Nov 2017 7:00 am
RNS
Arix to present at two IR conferences
18 Oct 2017 1:31 pm
RNS
Arix notes Harpoon AbbVie IO collaboration
17 Oct 2017 7:10 am
RNS
Director Declaration
  7:00 am
RNS
Giles Kerr Appointed to Board of Directors
10 Oct 2017 7:00 am
RNS
Arix Bioscience notes positive data from Amplyx
26 Sep 2017 7:00 am
RNS
Arix participates in $80 million Autolus financing
18 Sep 2017 7:20 am
RNS
Clinical progress from Autolus
  7:00 am
RNS
Capital Markets Meeting Today
14 Sep 2017 7:00 am
RNS
Arix Bioscience Capital Markets Meeting
08 Sep 2017 4:27 pm
RNS
Arix to present at Rodman & Renshaw conference
07 Sep 2017 2:00 pm
RNS
Arix notes positive Verona data in COPD
04 Sep 2017 7:05 am
RNS
Arix Bioscience notes Artios CSO Appointment
02 Aug 2017 7:00 am
RNS
Arix participates in $67m financing for Amplyx
31 Jul 2017 7:00 am
RNS
Report for the Six Months Ended 30 June 2017
27 Jul 2017 7:00 am
RNS
Arix Bioscience: $29M Series A for PreciThera
21 Jul 2017 3:17 pm
RNS
Meghan FitzGerald appointed to Board of Directors
17 Jul 2017 7:00 am
RNS
Notice of Results
10 Jul 2017 7:00 am
RNS
Arix Bioscience plc Appoints General Counsel
28 Jun 2017 7:00 am
RNS
Arix Bioscience leads $45M financing round
27 Jun 2017 12:00 pm
RNS
Arix Bioscience in $20M Mitoconix Bio fundraise
12 Jun 2017 7:01 am
RNS
Arix notes Artios collaboration
05 Jun 2017 3:45 pm
RNS
Result of AGM
  7:00 am
RNS
Director/PDMR Shareholding
31 May 2017 7:00 am
RNS
Arix to present at Jefferies Healthcare Conference
30 May 2017 7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Appointment of Jefferies and Stifel as brokers
26 May 2017 4:35 pm
RNS
Price Monitoring Extension
25 May 2017 7:00 am
RNS
Arix Bioscience Leads Harpoon Therapeutics Round
19 May 2017 7:00 am
RNS
Arix leads $65m Series B investment for Iterum
09 May 2017 7:00 am
RNS
Director share purchases
28 Apr 2017 12:04 pm
RNS
Arix Notes Verona's NASDAQ Listing
  8:00 am
RNS
Annual Financial Report
18 Apr 2017 12:00 pm
RNS
Group business Verona receives IND for RPL554
31 Mar 2017 7:00 am
RNS
Board Committee Changes
22 Mar 2017 2:52 pm
RNS
Holding(s) in Company
20 Mar 2017 7:05 am
RNS
Arix Bioscience, LDC, Leeds University Agreement
  7:02 am
RNS
Partial Exercise of Over-Allotment Option
  7:01 am
RNS
End of Stabilisation Notice
  7:00 am
RNS
Mid-Stabilisation Period Announcement
10 Mar 2017 4:30 pm
RNS
Mid-Stabilisation Period Announcement
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
08 Mar 2017 7:00 am
RNS
Holding(s) in Company
06 Mar 2017 7:00 am
RNS
Holdings in Company
  7:00 am
RNS
Holdings in Company
02 Mar 2017 7:00 am
RNS
Arix signs strategic agreement with Takeda
28 Feb 2017 4:30 pm
RNS
Mid-Stabilisation Period Announcement
22 Feb 2017 8:08 am
RNS
Arix Bioscience - admission to trading
17 Feb 2017 7:01 am
RNS
Stabilisation Notice
  7:00 am
RNS
Arix Bioscience raises �100m in IPO

a d v e r t i s e m e n t